Mesothelioma Cancer Centers
University of Nebraska Medical Center
Doctors Affiliated with this Treatment Facility
The Fred & Pamela Buffett Cancer Center at the University of Nebraska Medical Center houses experts in both lung and peritoneal cancers, giving them the capability to treat different forms of mesothelioma cancer. Their team implements advanced diagnostic and treatment methods to provide patients with options for treating their cancer. Specialists at the center use a new minimally invasive biopsy option known as electromagnet navigation bronchoscopy, which is guided by the computer and allows for multiple samples to be taken at once for better analysis.
Their peritoneal cancer care involves leading treatments in surgical cytoreduction (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC), which work together to improve the quality and length of a patient’s life. The treatment works by removing the visible sites of cancer surgically, combined with instilling heated chemotherapy throughout the abdominal cavity. Their lung cancer treatment center utilizes advanced treatment options such as video-assisted thoracoscopic surgery (VATS) to deliver high-quality treatment for patients with lung conditions, including pleural mesothelioma.
Clinical trials are also available to patients who are eligible, providing more options for advanced treatment options. Palliative care and personal care are provided to patients at Nebraska Medicine to help them manage symptoms and hardships associated with their cancer diagnosis. Patients can also seek support groups, nutrition help, financial counseling and other support services through the center.
- CAR T-Cell
- Hyperthermic Intraperitoneal Chemotherapy
- Palliative care
- Radiation therapy
- Surgical Cytoreduction
- High Performing Hospital for Lung Cancer Surgery by U.S. News & World Report
- Best Regional Hospital by U.S. News & World Report
- Lung Cancer Alliance Screening Center of Excellence
Mesothelioma Clinical Trials at University of Nebraska Medical Center
The following clinical trials are in progress or actively recruiting participants at University of Nebraska Medical Center:
Conditions: Pancreatic Cancer; Thyroid Cancer; Lung Cancer; Esophageal Cancer; Thymus Cancer; Colon Cancer; Rectal Cancer; GIST; Anal Cancer; Bile Duct Cancer; Duodenal Cancer; Gallbladder Cancer; Gastric Cancer; Liver Cancer; Small Intestine Cancer; Peritoneal Surface Malignancies; Familial Adenomatous Polyposis; Lynch Syndrome; Bladder Cancer; Kidney Cancer; Penile Cancer; Prostate Cancer; Testicular Cancer; Ureter Cancer; Urethral Cancer; Hypopharyngeal Cancer; Laryngeal Cancer; Lip Cancer; Oral Cavity Cancer; Nasopharyngeal Cancer; Oropharyngeal Cancer; Paranasal Sinus Cancer; Nasal Cavity Cancer; Salivary Gland Cancer; Skin Cancer; CNS Tumor; CNS Cancer; Mesothelioma; Breastcancer; Leukemia; Melanoma; Sarcoma; Unknown Primary Tumor; Multiple Myeloma; Ovarian Cancer; Endometrial Cancer; Vaginal Cancer Last Updated: November 1, 2018 Status: Recruiting
Author: Linda Molinari
Editor in Chief, Mesothelioma Cancer AllianceRead about Linda
Reviewer: Annette Charlevois
Patient Support CoordinatorRead about Annette